secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001213900-24-095926
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionomics announces amended exchange ratio for re-domicile merger; court approves Dec 12 meeting
--------------------------------------------------------------------------------

- Amended exchange ratio: 1 Neuphoria share per 2,160 Bionomics ordinary shares; 1 per 12 ADSs.
- Supreme Court of New South Wales approved convening of shareholder meeting on Dec 12, 2024.
- Bionomics has Nasdaq minimum bid price deficiency notice; expects compliance after scheme completion.
- Re-domicile from Australia to Delaware; Neuphoria common stock to list on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024095926/0001213900-24-095926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024095926/ea0218750-8k_bionomics.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer